Arrowhead Pharmaceuticals, Inc. (ARWR) NASDAQ
55.05
+0.04(+0.07%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
55.05
+0.04(+0.07%)
Currency In USD
| Market Cap | 4.61B |
| Enterprise Value | 4.75B |
| P/E Ratio | 38.12 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 7.07 |
| Price/Book Ratio | 13.56 |
| Enterprise/Revenue | 7.17 |
| Enterprise/EBITDA | 21.12 |
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.19 |
| Operating Margin | 0.28 |
| Return On Assets | 0.13 |
| Return On Equity | 0.36 |
| Revenue | 829.45M |
| Revenue/Share | 7.79 |
| Gross Profit | 805.52M |
| EBITDA | 164.82M |
| Net Income | -1.63M |
| Diluted EPS | -0.01 |
| Total Cash | 916.61M |
| Total Cash/Share | 6.54 |
| Total Debt | 312.77M |
| Total Debt/Equity | 0.55 |
| Current Ratio | 3.38 |
| Book Value Per Share | 4.02 |
| 52-Week Change | 258.4 |
| 52-Week High | 76.76 |
| 52-Week Low | 9.57 |
| Moving Average 50 Days | 64.85 |
| Moving Average 200 Days | 40.19 |
| Average Volume | 2.84M |
| Shares Outstanding | 140.03M |
| % Held by Institutions | 82.82 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | November 17, 2011 |